CD8A and neoplasm: It was reported that CD4+ helper and CD8+ cytotoxic T cells exert a synergistic antitumor effect in a 1:1 ratio, positively influencing tumor eradication [52], and achieve high remission rates during the treatment of B-ALL patients with CD19 CAR-T cells [15].